Financials

  • Market Capitalization 405.36 M
  • Employee 40
  • Founded 2022
  • CEO N/A
  • Website www.zurabio.com
  • Headquarter Cayman Islands
  • FIGI UNKNOWN
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.94
Rapporto prezzo/fatturato
100.37

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2983
TECX
Tectonic Therapeutic, Inc. - Common Stock
21.31 USD-4.65%-4.14%-28.27%+24.26%416.60 M USD
2984
ASMB
Assembly Biosciences, Inc. - Common Stock
20.34 USD-10.67%-7.33%-29.86%-30.88%414.13 M USD
2995
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
4.05 USD-3.11%-4.48%-10.00%-56.03%402.76 M USD
3002
CAPR
Capricor Therapeutics, Inc. - Common Stock
6.88 USD-7.90%-9.35%-22.08%+2.38%400.00 M USD

Notizie